These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Zhu X; Lazow MA; Schafer A; Bartlett A; Senthil Kumar S; Mishra DK; Dexheimer P; DeWire M; Fuller C; Leach JL; Fouladi M; Drissi R Acta Neuropathol Commun; 2021 Jan; 9(1):14. PubMed ID: 33431066 [TBL] [Abstract][Full Text] [Related]
12. Advances and Clinical Trials Update in the Treatment of Diffuse Intrinsic Pontine Gliomas. Dalle Ore C; Coleman C; Gupta N; Mueller S Pediatr Neurosurg; 2023; 58(5):259-266. PubMed ID: 36642062 [TBL] [Abstract][Full Text] [Related]
13. Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG. Nikolaev A; Fiveash JB; Yang ES Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940975 [TBL] [Abstract][Full Text] [Related]
14. Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease. Qi J; Esfahani DR; Huang T; Ozark P; Bartom E; Hashizume R; Bonner ER; An S; Horbinski CM; James CD; Saratsis AM Acta Neuropathol Commun; 2019 May; 7(1):75. PubMed ID: 31092287 [TBL] [Abstract][Full Text] [Related]
15. TP53 Pathway Alterations Drive Radioresistance in Diffuse Intrinsic Pontine Gliomas (DIPG). Werbrouck C; Evangelista CCS; Lobón-Iglesias MJ; Barret E; Le Teuff G; Merlevede J; Brusini R; Kergrohen T; Mondini M; Bolle S; Varlet P; Beccaria K; Boddaert N; Puget S; Grill J; Debily MA; Castel D Clin Cancer Res; 2019 Nov; 25(22):6788-6800. PubMed ID: 31481512 [TBL] [Abstract][Full Text] [Related]